(Rₚ)-1-Dicyclohexylphosphino-2-[(R)-α-(dimethylamino)-2-(dicyclohexylphosphino)benzyl]ferrocene ≥95%
R464227-100MG / 100MG
CAS:1016985-24-2
(Rₚ)-1-Dicyclohexylphosphino-2-[(R)-α-(dimethylamino)-2-(dicyclohexylphosphino)benzyl]ferrocene ≥95%
R464227-1G / 1G
CAS:1016985-24-2
(Rₚ)-1-Dicyclohexylphosphino-2-[(R)-α-(dimethylamino)-2-(dicyclohexylphosphino)benzyl]ferrocene ≥95%
R464227-500MG / 500MG
CAS:1016985-24-2
(R)-1-[(Sₚ)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine palladium(II) dichloride ≥97%
R464263-100MG / 100MG
CAS:854019-82-2
(R)-1-[(Sₚ)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine palladium(II) dichloride ≥97%
R464263-1G / 1G
CAS:854019-82-2
(R)-1-[(Sₚ)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine palladium(II) dichloride ≥97%
R464263-5G / 5G
CAS:854019-82-2
(R)-(+)-α,α-Diphenyl-2-pyrrolidinemethanol tert-butyldimethylsilyl ether ≥97%(HPLC)
R464327-1G / 1G
CAS:1236033-34-3
(R)-(+)-α,α-Diphenyl-2-pyrrolidinemethanol tert-butyldimethylsilyl ether ≥97%(HPLC)
R464327-250MG / 250MG
CAS:1236033-34-3
(R)-(+)-α,α-Diphenyl-2-pyrrolidinemethanol tert-butyldimethylsilyl ether ≥97%(HPLC)
R464327-5G / 5G
CAS:1236033-34-3
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-dimethylphenyl)phosphine] ≥97%(CHN),≥99%(ee)
R464366-100MG / 100MG
CAS:394248-45-4
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-dimethylphenyl)phosphine] ≥97%(CHN),≥99%(ee)
R464366-1G / 1G
CAS:394248-45-4
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-dimethylphenyl)phosphine] ≥97%(CHN),≥99%(ee)
R464366-500MG / 500MG
CAS:394248-45-4
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-dimethylphenyl)phosphine] ≥97%(CHN),≥99%(ee)
R464366-5G / 5G
CAS:394248-45-4
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-butylphenyl)phosphine] ≥97%,≥99%(ee)
R464385-100MG / 100MG
CAS:192138-05-9
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-butylphenyl)phosphine] ≥97%,≥99%(ee)
R464385-1G / 1G
CAS:192138-05-9
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-butylphenyl)phosphine] ≥97%,≥99%(ee)
R464385-500MG / 500MG
CAS:192138-05-9
(R)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(3,5-di-tert-butylphenyl)phosphine] ≥97%,≥99%(ee)
R464385-5G / 5G
CAS:192138-05-9
(1R,4S)-(+)-4-(Fmoc-amino)-2-cyclopentene-1-carboxylic acid ≥97%(HPLC)(sum of enantiomers)
R464554-100MG / 100MG
CAS:220497-65-4
(1R,4S)-(+)-4-(Fmoc-amino)-2-cyclopentene-1-carboxylic acid ≥97%(HPLC)(sum of enantiomers)
R464554-1G / 1G
CAS:220497-65-4
(1R,4S)-(+)-4-(Fmoc-amino)-2-cyclopentene-1-carboxylic acid ≥97%(HPLC)(sum of enantiomers)
R464554-250MG / 250MG
CAS:220497-65-4
(2R)-N-[(1R)-1-(Hydroxydiphenylmethyl)-3-methylbutyl]-2-pyrrolidinecarboxamide ≥98%(HPLC)
R465153-100MG / 100MG
CAS:1088110-92-2
(1R,4S)-cis-4-Acetoxy-2-cyclopenten-1-ol ≥98%(GC), sum of enantiomers
R465383-500MG / 500MG
CAS:60176-77-4